Multigene Panel

{
  "compose" : {
    "exclude" : [ ],
    "include" : [ {
      "system" : "http://www.ama-assn.org/go/cpt",
      "extension" : [ {
        "extension" : [ {
          "valueString" : "concept",
          "url" : "path"
        }, {
          "url" : "count",
          "valueInteger" : 2
        } ],
        "url" : "http://health-samurai.io/extensions/excised-data"
      } ]
    } ]
  },
  "date" : "2023-07-07T01:01:08-04:00",
  "meta" : {
    "versionId" : "7",
    "lastUpdated" : "2023-12-21T17:43:03.000-05:00",
    "profile" : [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ]
  },
  "publisher" : "American Society of Clinical Oncology Steward",
  "jurisdiction" : [ {
    "coding" : [ {
      "system" : "urn:iso:std:iso:3166",
      "code" : "US"
    } ]
  } ],
  "purpose" : "(Clinical Focus: The purpose of this value set is to represent concepts for the procedure of multigene panel.),(Data Element Scope: This value set may use a model element related to Procedure.),(Inclusion Criteria: Includes concepts that represent a procedure for multigene panel that includes testing for BRCA1 and BRCA2.),(Exclusion Criteria: No exclusions.)",
  "name" : "MultigenePanel",
  "resourceType" : "ValueSet",
  "expansion" : {
    "contains" : [ {
      "system" : "http://www.ama-assn.org/go/cpt",
      "code" : "81432",
      "display" : "Hereditary breast cancer-related disorders (eg, hereditary breast cancer, hereditary ovarian cancer, hereditary endometrial cancer); genomic sequence analysis panel, must include sequencing of at least 10 genes, always including BRCA1, BRCA2, CDH1, MLH1, MSH2, MSH6, PALB2, PTEN, STK11, and TP53",
      "version" : "2024"
    }, {
      "system" : "http://www.ama-assn.org/go/cpt",
      "code" : "81433",
      "display" : "Hereditary breast cancer-related disorders (eg, hereditary breast cancer, hereditary ovarian cancer, hereditary endometrial cancer); duplication/deletion analysis panel, must include analyses for BRCA1, BRCA2, MLH1, MSH2, and STK11",
      "version" : "2024"
    } ],
    "total" : 2,
    "identifier" : "urn:uuid:9c019874-0c4b-42f9-a178-3bede5601827",
    "timestamp" : "2024-06-14T15:50:40-04:00"
  },
  "title" : "Multigene Panel",
  "extension" : [ {
    "valueString" : "American Society of Clinical Oncology Author",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author"
  }, {
    "valueDate" : "2023-07-07",
    "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate"
  }, {
    "valueDate" : "2023-07-07",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate"
  }, {
    "url" : "http://health-samurai.io/extensions/source",
    "valueCode" : "db"
  } ],
  "status" : "active",
  "id" : "2.16.840.1.113883.3.1444.3.210",
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.210",
  "identifier" : [ {
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:oid:2.16.840.1.113883.3.1444.3.210"
  } ],
  "version" : "20230707"
}